Early research (Phase 1)Study completedNCT03436498
What this trial is testing
Safety Assessment of SAR341402 and NovoLog® Used in Continuous Subcutaneous Insulin Infusion for Type 1 Diabetes Mellitus Patients
Who this might be right for
Type 1 Diabetes Mellitus
Sanofi 45